These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2884654)

  • 1. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L; Ljungberg T; Rodebjer A; Ogren SO; Ungerstedt U
    Pharmacol Toxicol; 1987 Mar; 60(3):227-32. PubMed ID: 2884654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unique effect of remoxipride on dopamine utilization in the basal ganglia.
    Fuxe K; Ogren SO
    Acta Physiol Scand; 1991 Apr; 141(4):577-8. PubMed ID: 1678908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological and behavioural properties of remoxipride in the rat.
    Ogren SO; Florvall L; Hall H; Magnusson O; Angeby-Möller K
    Acta Psychiatr Scand Suppl; 1990; 358():21-6. PubMed ID: 1978483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different behavioural patterns induced by the dopamine agonist apomorphine analysed by multivariate statistics.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Feb; 24(2):291-8. PubMed ID: 3952117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O; Fowler CJ; Mohringe B; Wijkström A; Ogren SO
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):379-84. PubMed ID: 2900472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O; Fowler CJ; Köhler C; Ogren SO
    Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys.
    Gerlach J; Casey DE
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):103-12. PubMed ID: 1967845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and morphological differences in the behavioural response to apomorphine in rats.
    Havemann U; Magnus B; Möller HG; Kuschinsky K
    Psychopharmacology (Berl); 1986; 90(1):40-8. PubMed ID: 3094060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural correlates of modified dopaminergic/anticholinergic responses following chronic treatment with neuroleptic agents of differing activity spectra.
    Costall B; Naylor RJ; Owen RT
    Eur J Pharmacol; 1978 Mar; 48(1):29-36. PubMed ID: 25189
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.
    Dall'Olio R; Roncada P; Vaccheri A; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1989; 98(3):342-6. PubMed ID: 2568655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.